Community Tissue Services (CTS), headquartered in the United States, is a leading non-profit organisation in the field of tissue banking. Founded in 1992, CTS has established itself as a vital player in the regenerative medicine industry, specialising in the recovery, processing, and distribution of human tissue for transplantation. With operational regions spanning across the US, the organisation is committed to enhancing patient outcomes through innovative tissue solutions. CTS offers a diverse range of core products, including allografts for orthopaedic, spinal, and wound care applications. What sets them apart is their dedication to quality and safety, ensuring that every graft meets rigorous standards. Recognised for their contributions to the field, Community Tissue Services has achieved significant milestones, positioning itself as a trusted partner in the healthcare community, dedicated to improving lives through the gift of tissue donation.
How does Community Tissue Services's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Community Tissue Services's score of 18 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Community Tissue Services, headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of emissions figures. The organisation is a current subsidiary and does not inherit emissions data from a parent company. In terms of climate commitments, there are no documented reduction targets or initiatives such as Science-Based Targets Initiative (SBTi) commitments or specific climate pledges. This lack of data suggests that Community Tissue Services may still be in the early stages of formalising its climate strategy and emissions reporting. As the industry increasingly prioritises sustainability, Community Tissue Services may benefit from establishing clear emissions reduction goals and participating in recognised climate initiatives to enhance its environmental impact and transparency.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Community Tissue Services has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

